Urocit®-K (potassium citrate)

Switch to mobile view »

To Help Protect You From Another Kidney Stone Attack

If you've ever suffered from a kidney stone attack you will probably do anything in your power to prevent a recurrence. Luckily there's a specific preventative medical treatment that can greatly reduce the likelihood of your having another stone attack: Urocit®-K.

Illustration of Urocit-K wax-matrix tablet

Urocit®-K is a patented formulation of potassium citrate. Urocit®-K is available in slow-release wax-matrix tablets in 540 mg and 1080 mg strengths. Urocit®-K is indicated for the treatment of calcium and uric acid kidney stones.

Urocit®-K is clinically proven to inhibit the formation of most stones in over 90% of patients.

How Urocit®-K Works

Urocit®-K corrects the pH of the urine and elevates a naturally occurring urinary inhibitor. This helps control the formation of new stones.

Urocit®-K's Delivery System

Urocit®-K utilizes a wax-matrix delivery system. This wax-matrix system delivers a slow, sustained release of medication which allows for convenient dosing, less gastrointestinal upset, and enhanced patient compliance.

This material is intended to provide basic information. All medical advice, diagnosis and treatment should be obtained from your physician.

Urocit® -K (potassium citrate)

Inhibits formation of both calcium oxalate and uric acid stones
Website»

Thiola® (tiopronin)

For the prevention of cystine kidney stone formation
Website»

Lithostat® (acetohydroxamic acid)

Adjunctive therapy in patients with chronic urea-splitting urinary infection
Website»

StoneDisease.org

Information about the causes, symptoms, diagnosis, and treatment of stone disease Website»